In2Pharma
  • Home
  • Services
    • Regulatory Affairs
    • Quality Assurance
    • Publicity and Compliance
    • Medical writing & training
    • Vigilance
  • About Us
  • News
  • Contact
Select Page
Guidance for industry to prevent and mitigate medicine shortages

Guidance for industry to prevent and mitigate medicine shortages

by In2Pharma | Jun 27, 2023 | News

Europe EMA has published recommendations for industry on good practices to ensure continuity in the supply of human medicines, prevent shortages and reduce their impact . Medicine shortages are a global health problem and are increasingly affecting European...
Compliance and Ethics: new guidelines help MedTech companies partner with patient organisations

Compliance and Ethics: new guidelines help MedTech companies partner with patient organisations

by In2Pharma | Aug 10, 2021 | News

Europe On 3 June, MedTech Europe published a Guidance on the Interactions between the Medical Technology Industry and Patient Organisations (PO). The aim of this Guidance is to explain the rationale underpinning current interactions between the MedTech industry and PO...
New reporting point for medication incidents in the Netherlands

New reporting point for medication incidents in the Netherlands

by In2Pharma | Mar 30, 2021 | News

The Netherlands As from 1 January 2021, there is a new national reporting point for healthcare professionals (i.e. doctors, pharmacists…) to report any kind of incidents with medication: from errors in the prescription up to the administration of medicines, including...
Publication of Guidance document for the Regulation on the mutual recognition of goods

Publication of Guidance document for the Regulation on the mutual recognition of goods

by In2Pharma | Mar 29, 2021 | News

Europe Regulation (EU) 2019/515 on the mutual recognition of goods lawfully marketed in another Member State started to apply on 19 April 2020 and replaced Regulation (EC) No 764/2008. The aim of the Regulation is to strengthen the functioning of the single market by...
COVID-19 – Guidance for marketing authorisation holders, manufacturers and importers of human medicines

COVID-19 – Guidance for marketing authorisation holders, manufacturers and importers of human medicines

by In2Pharma | Jul 7, 2020 | News

Europe The European Commission, the European Medicines Agency (EMA) and the Heads of Medicines Agencies (HMA) have agreed on a series of measures to mitigate the impact of disruptions caused by COVID-19 on the conduct of inspections of manufacturing facilities or...
« Older Entries

Recent Posts

  • List unavailable medical devices
  • From July 1, more procedures via CBG planning tool
  • New pharmacovigilance bulletin launched by Santé Publique Luxembourg
  • New limit for Vitamin B6 in food supplements under consideration in the Netherlands
  • Refresher: mandatory application for export (RD 19/01/2023)

Follow Us

  • Facebook
  • LinkedIn
Privacy Policy | Cookie Policy | BTW BE 895730662 | +32 16 89 16 00| info@in2pharma.com | Terloonststraat 22, 1910 Kampenhout, België